Newer Therapies in Rheumatology.
Med Clin North Am
; 108(5): 829-842, 2024 Sep.
Article
in En
| MEDLINE
| ID: mdl-39084836
ABSTRACT
Seven of the 11 newer medications recently or soon to be approved to treat rheumatologic diseases discussed in this article are biologic agents and reflect the current ability of science to target specific components of the immune system. The other agents are molecules that are directed against specific immune pathway targets as well. All have shown superiority to placebo and in some cases have been compared to currently accepted therapies. Safety issues are generally centered around infections due to the immune-interrupting nature of these therapies.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rheumatic Diseases
/
Antirheumatic Agents
Limits:
Humans
Language:
En
Journal:
Med Clin North Am
/
Med. clin. North America
/
Medical clinics of North America
Year:
2024
Type:
Article
Affiliation country:
United States